Saturday, July 11, 2026

Drug profile · INN

lanthanum

lanthanum (FOSRENOL) is a phosphate sequestering agent. Associated with Lacuna Pharma Pty Ltd.

TGA: approved
Patents linked 0
Pipeline programs 7
News articles 0
Drug details — lanthanum

Quick answer

lanthanum (FOSRENOL) is a phosphate sequestering agent. Associated with Lacuna Pharma Pty Ltd.

Key facts

INN lanthanum
Brand FOSRENOL
Mechanism Phosphate sequestering agent
Target Phosphate

Mechanism of action

Phosphate sequestering agent

Primary target: Phosphate

Approval history

Authority Status Date
TGA approved

Pipeline programs

  1. Fosrenol (Lanthanum Carbonate) Phase 3 · Takeda · Chronic Kidney Disease, Stage 5
  2. Lanthanum Polystyrene Sulphonate Powder Phase 2 · First People's Hospital · Hyperphosphatemia
  3. Lanthanum carbonate Phase 2 · Takeda · Chronic Kidney Disease
  4. Oxylanthanum Carbonate Phase 2 · Unicycive Therapeutics · Chronic Kidney Disease Requiring Chronic Dialysis
  5. Lanthanum carbonate Granule Formulation Phase 1 · Takeda · End Stage Renal Disease
  6. Lanthanum carbonate Approved · Takeda · Kidney Failure, Chronic
  7. Lanthanum carbonate Approved · Takeda · Kidney Diseases

Related & competitor drugs

  1. alendronate sodium Farnesyl diphosphate synthase inhibitor
  2. calcium acetate Phosphate sequestering agent
  3. ferric citrate Phosphate sequestering agent
  4. ferric citrate coordination complex Various (V03)
  5. fingolimod hydrochloride Sphingosine 1-phosphate receptor agonist
  6. fingolimod lauryl sulfate Sphingosine 1-phosphate receptor binding agent

Frequently asked questions

What is lanthanum?

lanthanum (FOSRENOL) is a phosphate sequestering agent. Associated with Lacuna Pharma Pty Ltd.

What is the brand name for lanthanum?

FOSRENOL is a marketed brand name for lanthanum. Check FDA Drugs@FDA for the current US label holder and prescribing information.